Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients

Clinical trial NCT00270894 · COMPLETED

Trial details

NCT number: NCT00270894
Sponsor: Accelerated Community Oncology Research Network
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasm

Start date: 2005-11-01
Primary completion: 2011-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.